Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Subcommittee orders study on therapeutic interchange coverage by insurers
2128325 · January 17, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
Summary
SB 745 would direct the Board of Pharmacy to convene stakeholders and report by Nov. 15, 2025 on whether various insurer types cover therapeutic interchange drugs and what changes could improve coverage and cost outcomes.
Senator Jennifer McClellan Favola (referred to as Senator Favola in transcript) presented SB 745, a section 1 bill directing the Board of Pharmacy to convene stakeholders to examine coverage of therapeutic interchange drugs across payer types—federal (branded…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans
